FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018145466> ?p ?o ?g. }

• W2018145466 abstract "Exercise has favorable effects on biomarkers associated with a lower risk of breast cancer, however it is unclear if higher doses of exercise provide additional effects. No clinical trial has systematically examined how different exercise volumes influence the mechanisms underlying breast cancer etiology. The Breast Cancer and Exercise Trial in Alberta (BETA) - a follow-up study to the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial - is examining how a one-year, high versus moderate volume aerobic exercise intervention influences several biomechanisms hypothesized to influence breast cancer risk in a group of postmenopausal women. Secondary aims are to compare intervention effects on psychosocial and quality of life outcomes as well as understand exercise adherence at 12 and 24 months, and maintenance of all study outcomes at 24 months. The BETA Trial is a two-center, two-armed randomized controlled exercise intervention trial conducted in 400 previously inactive, postmenopausal women aged 50–74 years, in Alberta, Canada. Participants were randomly assigned to a one-year aerobic exercise intervention of either high volume (300 minutes/week) or moderate volume (150 minutes/week). Blood draws and accelerometry were performed at baseline, six and 12 months. Baseline and 12-month measurements were taken of adiposity (including dual energy X-ray absorptiometry and computed tomography scans), physical fitness, dietary intake, self-reported physical activity and sedentary behavior, quality of life, perceived stress, happiness, sleep, and determinants of exercise adherence. Exercise maintenance was assessed and all study measurements were repeated at 24 months. Blood will be analyzed for endogenous estrogens, insulin resistance indicators, and inflammatory markers. The BETA Trial will compare the impact of a high versus moderate volume of aerobic exercise on a variety of biological, physiological, and psychological outcomes of relevance to postmenopausal women. A tightly controlled exercise intervention and objective outcome measurements are methodological strengths. The BETA Trial will inform future prevention initiatives by assessing adherence to a high volume of exercise over 12 months by postmenopausal women, and the ability of these women to maintain activity over the longer-term. The ultimate objective is to inform public health guidelines for reducing breast cancer risk through physical activity. Clinical Trials Registration Number: NCT01435005" @default.
• W2018145466 created "2016-06-24" @default.
• W2018145466 creator A5008114614 @default.
• W2018145466 creator A5013855410 @default.
• W2018145466 creator A5024065548 @default.
• W2018145466 creator A5025127315 @default.
• W2018145466 creator A5038203538 @default.
• W2018145466 creator A5047611713 @default.
• W2018145466 creator A5064878925 @default.
• W2018145466 creator A5070269857 @default.
• W2018145466 creator A5070777309 @default.
• W2018145466 date "2014-12-01" @default.
• W2018145466 modified "2023-09-27" @default.
• W2018145466 title "Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA)" @default.
• W2018145466 cites W133204577 @default.
• W2018145466 cites W1515419808 @default.
• W2018145466 cites W16531278 @default.
• W2018145466 cites W1882801942 @default.
• W2018145466 cites W1962096292 @default.
• W2018145466 cites W1966435462 @default.
• W2018145466 cites W1975946962 @default.
• W2018145466 cites W1978529922 @default.
• W2018145466 cites W1994019767 @default.
• W2018145466 cites W1996299251 @default.
• W2018145466 cites W2000525505 @default.
• W2018145466 cites W2002336468 @default.
• W2018145466 cites W2002471807 @default.
• W2018145466 cites W2006153198 @default.
• W2018145466 cites W2010831031 @default.
• W2018145466 cites W2015039177 @default.
• W2018145466 cites W2020937999 @default.
• W2018145466 cites W2024459972 @default.
• W2018145466 cites W2031306701 @default.
• W2018145466 cites W2032883806 @default.
• W2018145466 cites W2037377025 @default.
• W2018145466 cites W2037989549 @default.
• W2018145466 cites W2045065444 @default.
• W2018145466 cites W2054695124 @default.
• W2018145466 cites W2057549357 @default.
• W2018145466 cites W2059565865 @default.
• W2018145466 cites W2062526070 @default.
• W2018145466 cites W2066805052 @default.
• W2018145466 cites W2071637386 @default.
• W2018145466 cites W2074276081 @default.
• W2018145466 cites W2082410281 @default.
• W2018145466 cites W2088949718 @default.
• W2018145466 cites W2093969963 @default.
• W2018145466 cites W2094280334 @default.
• W2018145466 cites W2095442891 @default.
• W2018145466 cites W2096528587 @default.
• W2018145466 cites W2097813641 @default.
• W2018145466 cites W2099697766 @default.
• W2018145466 cites W2108089942 @default.
• W2018145466 cites W2110141259 @default.
• W2018145466 cites W2110188848 @default.
• W2018145466 cites W2110821045 @default.
• W2018145466 cites W2112352881 @default.
• W2018145466 cites W2115016015 @default.
• W2018145466 cites W2117807651 @default.
• W2018145466 cites W2118094272 @default.
• W2018145466 cites W2121467598 @default.
• W2018145466 cites W2122806520 @default.
• W2018145466 cites W2124466296 @default.
• W2018145466 cites W2125398770 @default.
• W2018145466 cites W2131355120 @default.
• W2018145466 cites W2131415741 @default.
• W2018145466 cites W2134155956 @default.
• W2018145466 cites W2139564598 @default.
• W2018145466 cites W2141290994 @default.
• W2018145466 cites W2143215975 @default.
• W2018145466 cites W2144160519 @default.
• W2018145466 cites W2144852094 @default.
• W2018145466 cites W2151487996 @default.
• W2018145466 cites W2154827797 @default.
• W2018145466 cites W2157384238 @default.
• W2018145466 cites W2157583343 @default.
• W2018145466 cites W2158234071 @default.
• W2018145466 cites W2160384736 @default.
• W2018145466 cites W2163316051 @default.
• W2018145466 cites W2163857792 @default.
• W2018145466 cites W2169604888 @default.
• W2018145466 cites W2169961966 @default.
• W2018145466 cites W2219978888 @default.
• W2018145466 cites W3124410800 @default.
• W2018145466 cites W4242498724 @default.
• W2018145466 cites W4292806894 @default.
• W2018145466 doi "https://doi.org/10.1186/1471-2407-14-919" @default.
• W2018145466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4364325" @default.
• W2018145466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25480020" @default.
• W2018145466 hasPublicationYear "2014" @default.
• W2018145466 type Work @default.
• W2018145466 sameAs 2018145466 @default.
• W2018145466 citedByCount "32" @default.
• W2018145466 countsByYear W20181454662015 @default.
• W2018145466 countsByYear W20181454662016 @default.
• W2018145466 countsByYear W20181454662017 @default.
• W2018145466 countsByYear W20181454662018 @default.
• W2018145466 countsByYear W20181454662019 @default.
• W2018145466 countsByYear W20181454662020 @default.
• W2018145466 countsByYear W20181454662021 @default.

• next